About: Economic burden of pneumococcal infections in children under 5 years of age

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Economic burden of pneumococcal infections in children under 5 years of age Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Economic burden of pneumococcal infections in children under 5 years of age
Creator	Aykac, Kubra Ceyhan, Mehmet Hacibedel, Basak Ozbilgili, Egemen Ozsurekci, Yasemin
Source	PMC
abstract	The present study aimed to determine the cost of childhood pneumococcal infections under 5 years of age and to provide further data for future health economy studies. Electronic medical records of children diagnosed with meningitis caused by S. pneumoniae and all-cause pneumonia, and acute otitis media (AOM) between January 2013-April 2014 were retrospectively evaluated. Direct costs for the treatments of hospitalized patients (pneumonia and pneumococcal meningitis) including costs of healthcare services consisted of costs of hospital bed, examination, laboratory analyses, scanning methods, consultation, vascular access procedures, and infusion and intravenous treatments. Direct costs for patients (AOM) treated in outpatient setting included constant price paid for the examination and cost of prescribed antibiotics. Indirect costs included cost of work loss of parents and their transportation expenses. Data of 130 children with pneumococcal meningitis (n = 10), pneumonia (n = 53), and AOM (n = 67) were analyzed. The total median cost was €4,060.38 (direct cost: €3,346.38 and indirect cost: €829.18) for meningitis, €835.91 (direct cost: €480.66 and indirect cost: €330.09) for pneumonia, and €117.32 (direct cost: €17.59 and indirect cost: €99.73) for AOM. The medication cost (p = 0.047), indirect cost (p = 0.032), and total cost (p = 0.011) were significantly higher in pneumonia patients aged ≥36 months than those aged <36 months; however, direct cost of AOM were significantly higher in the patients aged <36 months (p = 0.049). Results of the present study revealed that the treatment cost was significantly enhanced for hospitalization and for advanced disease. Thus, preventive actions, mainly vaccination, should be conducted regularly.
has issue date	2017-11-07(xsd:dateTime)
bibo:doi	10.1080/21645515.2017.1371378
bibo:pmid	28922054
has license	cc-by-nc-nd
sha1sum (hex)	aef9406b4054bc208dbb8735e5803fd25caa3eba
schema:url	https://doi.org/10.1080/21645515.2017.1371378
resource representing a document's title	Economic burden of pneumococcal infections in children under 5 years of age
has PubMed Central identifier	PMC5791583
has PubMed identifier	28922054
schema:publication	Hum Vaccin Immunother
resource representing a document's body	covid:aef9406b4054bc208dbb8735e5803fd25caa3eba#body_text
is schema:about of	named entity 'pneumococcal infections' named entity 'median' named entity 'direct cost' named entity 'cost' named entity 'determine' named entity 'preventive' named entity 'Data' named entity 'AOM' named entity 'costs' named entity 'otitis media' named entity '2014' named entity 'AGE' named entity 'PNEUMOCOCCAL INFECTIONS' covid:arg/aef9406b4054bc208dbb8735e5803fd25caa3eba named entity 'ADVANCED' named entity 'HOSPITALIZED PATIENTS' named entity 'MENINGITIS' named entity 'ACUTE OTITIS MEDIA' named entity '36 MONTHS' named entity 'TO PROVIDE' named entity 'ENHANCED' named entity 'INFUSION' named entity 'TREATMENT COST' named entity 'HEALTHCARE SERVICES' named entity 'STUDY' named entity 'CHILDREN' named entity 'CONSTANT' named entity 'PNEUMOCOCCAL MENINGITIS' named entity 'S. PNEUMONIAE' named entity 'VACCINATION' named entity 'HOSPITALIZATION' named entity 'HOSPITAL BED' named entity 'PARENTS' named entity 'YEARS' named entity 'FUTURE' named entity 'LABORATORY' named entity 'CHILDHOOD' named entity 'ANTIBIOTICS' named entity 'PRESENT' named entity 'PREVENTIVE' named entity 'CAUSED BY' named entity 'PRESCRIBED' named entity 'MONTHS' named entity 'KEYWORDS' named entity 'AC4' named entity 'ECONOMIC BURDEN' named entity 'DIAGNOSED' named entity 'METHODS' named entity 'EXAMINATION' named entity 'REVEALED' named entity 'YEARS' named entity 'CHILDREN' named entity 'LOSS OF' named entity 'AOM' named entity 'APRIL' named entity 'AC3' named entity 'COST' named entity 'INDIRECT COSTS' named entity '130' named entity 'AGE' named entity 'OUTPATIENT' named entity 'REGULARLY' named entity 'ECONOMIC BURDEN' named entity 'EXPENSES' named entity 'MEDICATION' named entity 'PATIENTS' named entity 'HIGHER' named entity 'TREATMENTS' named entity 'ECONOMY' named entity 'SCANNING' named entity 'INCLUDING' named entity 'WORK' named entity 'INTRAVENOUS' named entity 'PAID' named entity 'CONTACT' named entity 'PROCEDURES' named entity 'DATA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software